HCP (HCP) Upgraded to Buy at Stifel Nicolaus
Stifel Nicolaus upgraded shares of HCP (NYSE:HCP) from a hold rating to a buy rating in a report released on Tuesday morning. The brokerage currently has $29.00 price objective on the real estate investment trust’s stock.
Several other equities research analysts have also recently commented on HCP. BMO Capital Markets restated a hold rating and set a $32.00 price target on shares of HCP in a research note on Wednesday, September 6th. KeyCorp restated a hold rating on shares of HCP in a research note on Sunday, September 17th. Bank of America cut HCP from a buy rating to a neutral rating and cut their price target for the stock from $33.00 to $31.00 in a research note on Friday, September 22nd. Morgan Stanley cut their price target on HCP from $31.00 to $29.00 and set an equal weight rating for the company in a research note on Monday, September 25th. Finally, UBS cut HCP from a neutral rating to a sell rating and cut their price target for the stock from $30.00 to $25.00 in a research note on Monday, October 2nd. Three investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have given a buy rating to the company. The stock has a consensus rating of Hold and a consensus price target of $30.91.
HCP (HCP) traded up $0.16 during trading on Tuesday, hitting $26.56. The stock had a trading volume of 3,769,800 shares, compared to its average volume of 3,690,433. HCP has a twelve month low of $25.08 and a twelve month high of $33.67. The company has a debt-to-equity ratio of 1.17, a current ratio of 0.61 and a quick ratio of 0.61. The stock has a market capitalization of $12,384.46, a PE ratio of 12.82, a PEG ratio of 2.82 and a beta of 0.38.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 21st. Shareholders of record on Monday, November 6th were given a $0.37 dividend. This represents a $1.48 annualized dividend and a yield of 5.57%. The ex-dividend date of this dividend was Friday, November 3rd. HCP’s payout ratio is 133.33%.
A number of large investors have recently added to or reduced their stakes in the business. BlackRock Inc. increased its position in shares of HCP by 1.3% in the second quarter. BlackRock Inc. now owns 46,580,421 shares of the real estate investment trust’s stock valued at $1,488,710,000 after buying an additional 599,578 shares in the last quarter. Cohen & Steers Inc. increased its position in shares of HCP by 26.6% in the third quarter. Cohen & Steers Inc. now owns 35,762,597 shares of the real estate investment trust’s stock valued at $995,273,000 after buying an additional 7,524,081 shares in the last quarter. State Street Corp increased its position in shares of HCP by 0.3% in the second quarter. State Street Corp now owns 27,363,119 shares of the real estate investment trust’s stock valued at $874,524,000 after buying an additional 74,972 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of HCP by 2.3% in the second quarter. JPMorgan Chase & Co. now owns 23,442,708 shares of the real estate investment trust’s stock valued at $749,230,000 after buying an additional 521,915 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of HCP by 0.8% in the third quarter. Bank of New York Mellon Corp now owns 13,127,480 shares of the real estate investment trust’s stock valued at $365,337,000 after buying an additional 107,826 shares in the last quarter. Hedge funds and other institutional investors own 90.19% of the company’s stock.
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Receive News & Stock Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related stocks with our FREE daily email newsletter.